|
TCEANC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.542030E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.184200E-01 |
| Normal-vs-Stage2 |
1.815040E-01 |
| Normal-vs-Stage3 |
5.171700E-04 |
| Normal-vs-Stage4 |
8.46230000000059E-05 |
| Stage1-vs-Stage2 |
2.566200E-01 |
| Stage1-vs-Stage3 |
1.219710E-03 |
| Stage1-vs-Stage4 |
3.047200E-04 |
| Stage2-vs-Stage3 |
2.499600E-01 |
| Stage2-vs-Stage4 |
9.561800E-02 |
| Stage3-vs-Stage4 |
4.209000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.246440E-02 |
| Normal-vs-AfricanAmerican |
1.075520E-02 |
| Normal-vs-Asian |
1.761000E-01 |
| Caucasian-vs-AfricanAmerican |
1.699380E-01 |
| Caucasian-vs-Asian |
1.164570E-01 |
| AfricanAmerican-vs-Asian |
8.660200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.402320E-03 |
| Normal-vs-Female |
5.580800E-01 |
| Male-vs-Female |
1.006150E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.218560E-01 |
| Normal-vs-Age(41-60Yrs) |
1.141030E-01 |
| Normal-vs-Age(61-80Yrs) |
1.139890E-02 |
| Normal-vs-Age(81-100Yrs) |
8.392000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.390400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.275000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.219000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.065800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.355200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.345800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.532360E-01 |
| Normal-vs-Grade 2 |
8.862600E-01 |
| Normal-vs-Grade 3 |
2.989800E-04 |
| Normal-vs-Grade 4 |
3.81709999996982E-06 |
| Grade 1-vs-Grade 2 |
3.506400E-01 |
| Grade 1-vs-Grade 3 |
6.179600E-03 |
| Grade 1-vs-Grade 4 |
5.418700E-04 |
| Grade 2-vs-Grade 3 |
5.725599999995E-05 |
| Grade 2-vs-Grade 4 |
8.18199999974567E-07 |
| Grade 3-vs-Grade 4 |
6.369700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.643400E-01 |
| Normal-vs-ccB subtype |
1.218470E-03 |
| ccA subtype-vs-ccB subtype |
2.08969999999642E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.101700E-02 |
| Normal-vs-N1 |
1.372460E-04 |
| N0-vs-N1 |
3.458400E-02 |
|
|
